EDAP
Price
$1.83
Change
+$0.02 (+1.10%)
Updated
Jun 5, 04:17 PM (EDT)
Capitalization
281.62M
76 days until earnings call
SENS
Price
$0.53
Change
-$0.00 (-0.00%)
Updated
Jun 5, 04:40 PM (EDT)
Capitalization
281.84M
63 days until earnings call
Interact to see
Advertisement

EDAP vs SENS

Header iconEDAP vs SENS Comparison
Open Charts EDAP vs SENSBanner chart's image
EDAP TMS SA
Price$1.83
Change+$0.02 (+1.10%)
Volume$800
Capitalization281.62M
Senseonics Holdings
Price$0.53
Change-$0.00 (-0.00%)
Volume$29.4K
Capitalization281.84M
EDAP vs SENS Comparison Chart
Loading...
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SENS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDAP vs. SENS commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDAP is a Hold and SENS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (EDAP: $1.81 vs. SENS: $0.53)
Brand notoriety: EDAP and SENS are both not notable
EDAP represents the Medical Distributors, while SENS is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EDAP: 18% vs. SENS: 132%
Market capitalization -- EDAP: $281.62M vs. SENS: $281.84M
EDAP [@Medical Distributors] is valued at $281.62M. SENS’s [@Medical Specialties] market capitalization is $281.84M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDAP’s FA Score shows that 0 FA rating(s) are green whileSENS’s FA Score has 1 green FA rating(s).

  • EDAP’s FA Score: 0 green, 5 red.
  • SENS’s FA Score: 1 green, 4 red.
According to our system of comparison, SENS is a better buy in the long-term than EDAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDAP’s TA Score shows that 4 TA indicator(s) are bullish while SENS’s TA Score has 6 bullish TA indicator(s).

  • EDAP’s TA Score: 4 bullish, 6 bearish.
  • SENS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SENS is a better buy in the short-term than EDAP.

Price Growth

EDAP (@Medical Distributors) experienced а +3.99% price change this week, while SENS (@Medical Specialties) price change was +0.81% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.31%. For the same industry, the average monthly price growth was +0.72%, and the average quarterly price growth was -3.07%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.90%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +1.32%.

Reported Earning Dates

EDAP is expected to report earnings on Aug 20, 2025.

SENS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Distributors (+0.31% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

@Medical Specialties (+0.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDAP($282M) and SENS($282M) have the same market capitalization . EDAP has higher P/E ratio than SENS: EDAP (100.00) vs SENS (8.58). SENS YTD gains are higher at: 2.197 vs. EDAP (-18.100). EDAP has higher annual earnings (EBITDA): -18.39M vs. SENS (-48.01M). SENS has more cash in the bank: 109M vs. EDAP (43.5M). EDAP has less debt than SENS: EDAP (8.42M) vs SENS (47.8M). EDAP has higher revenues than SENS: EDAP (60.4M) vs SENS (22.4M).
EDAPSENSEDAP / SENS
Capitalization282M282M100%
EBITDA-18.39M-48.01M38%
Gain YTD-18.1002.197-824%
P/E Ratio100.008.581,165%
Revenue60.4M22.4M270%
Total Cash43.5M109M40%
Total Debt8.42M47.8M18%
FUNDAMENTALS RATINGS
EDAP vs SENS: Fundamental Ratings
EDAP
SENS
OUTLOOK RATING
1..100
102
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
9148
P/E GROWTH RATING
1..100
10027
SEASONALITY SCORE
1..100
n/a45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SENS's Valuation (59) in the Electronic Components industry is somewhat better than the same rating for EDAP (98) in the Biotechnology industry. This means that SENS’s stock grew somewhat faster than EDAP’s over the last 12 months.

SENS's Profit vs Risk Rating (99) in the Electronic Components industry is in the same range as EDAP (100) in the Biotechnology industry. This means that SENS’s stock grew similarly to EDAP’s over the last 12 months.

EDAP's SMR Rating (94) in the Biotechnology industry is in the same range as SENS (98) in the Electronic Components industry. This means that EDAP’s stock grew similarly to SENS’s over the last 12 months.

SENS's Price Growth Rating (48) in the Electronic Components industry is somewhat better than the same rating for EDAP (91) in the Biotechnology industry. This means that SENS’s stock grew somewhat faster than EDAP’s over the last 12 months.

SENS's P/E Growth Rating (27) in the Electronic Components industry is significantly better than the same rating for EDAP (100) in the Biotechnology industry. This means that SENS’s stock grew significantly faster than EDAP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDAPSENS
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 22 days ago
82%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SENS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CABNX15.69N/A
N/A
AB Global Risk Allocation A
WINAX10.40N/A
N/A
Wilmington International A
GEMHX12.49N/A
N/A
Goldman Sachs Emerging Mkts Eq ex. Chn A
PTPPX14.65N/A
N/A
Principal International Equity R5
OMSYX28.79N/A
N/A
Invesco Main Street All Cap Y

EDAP and

Correlation & Price change

A.I.dvisor tells us that EDAP and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDAP and AORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDAP
1D Price
Change %
EDAP100%
+0.84%
AORT - EDAP
29%
Poorly correlated
+0.74%
AVNS - EDAP
21%
Poorly correlated
+0.16%
SRDX - EDAP
21%
Poorly correlated
+1.66%
UFPT - EDAP
20%
Poorly correlated
+0.50%
SENS - EDAP
20%
Poorly correlated
+0.98%
More

SENS and

Correlation & Price change

A.I.dvisor tells us that SENS and ARAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SENS and ARAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SENS
1D Price
Change %
SENS100%
+0.98%
ARAY - SENS
31%
Poorly correlated
+1.27%
NAOV - SENS
31%
Poorly correlated
N/A
ICCM - SENS
28%
Poorly correlated
+0.98%
GMED - SENS
28%
Poorly correlated
-0.07%
OSUR - SENS
27%
Poorly correlated
-2.03%
More